Pretransplantation soluble adhesion molecule expression predicts outcome after living donor renal transplantation

Archives of Surgery

Volumn 138, Issue 10, 2003, Pages 1113-1120

  Perez, Richard V ^a,b   Huang, Charles Q ^a   Johnson, Jeremy R ^a   Gallay, Brian J ^a   Gandhi, Mehul M ^a   McVicar, John P ^a   Troppmann, Christoph ^a   Orloff, Susan L ^c   Freise, Chris E ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CELL ADHESION MOLECULE; CYCLOSPORIN; INTERCELLULAR ADHESION MOLECULE 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CORRELATION COEFFICIENT; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0141923908     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.138.10.1113     Document Type: Article

References (20)

1. Haverkate F, Thompson S, Pyke S, Gallimore J, Pepys M. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462-466.
2. Ridker P, Cushman M, Stampfer M, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
3. Ridker P, Cushman M, Stampfer M, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425-428.
4. Ridker P, Hennekens C, Roitman-Johnson B, Stampfer M, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 1998;351:88-92.
5. Libby R, Ridker P, Maseri A. Inflammation and atherosclerosis. Girculation. 2002;105:1135-1143.
6. Pradhan A, Rifai N, Ridker P. Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation. 2002;106:820-825.
7. Briscoe DM, Ganz P, Alexander SI, et al. The problem of chronic rejection: influence of leukocyte-endothelial interactions. Kidney Int. 1997;51(suppl 58):S22-S27.
8. Ballantyne C, Entman M. Soluble adhesion molecules and the search for biomarkers for atherosclerosis. Circulation. 2002;106:766-767.
9. Binder C, Chang M, Shaw P, et al. Innate and acquired immunity in atherogenesis. Nat Med. 2002;8:1218-1226.
10. Fox A, Harrison L. Innate immunity and graft rejection. Immunol Rev. 2000;173:141-147.
11. Perez R, Brown D, Katznelson S, et al. Pretransplant systemic inflammation and acute rejection after renal transplantation. Transplantation. 2000;69:869-874.
12. Huang C, Gandhi M, Troppmann C, et al. Pretransplant systemic inflammation and graft survival in living donor kidney transplant recipients. Am J Transplant. 2002;2(suppl 3):282-283.
13. Bevilacqua M, Nelson R, Mannori G, Cecconi O. Endothelial-leukocyte adhesion molecules in human disease. Ann Rev Med. 1994;45:361-378.
14. Fink J, Onuigbo MA, Blahut SA, et al. Pretransplant serum C-reactive protein and the risk of chronic allograft nephropathy in renal transplant recipients: a pilot case-control study. Am J Kidney Dis. 2002;39:1096-1101.
15. Labarrere C, Lee J, Nelson D, Al-Hassani M, Miller S, Pitts D. C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study. Lancet. 2002;360:1462-1467.
16. Kaysen G. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol. 2001;12:1549-1557.
17. Lowrie E. Chronic inflammation and clinical outcome in adult hemodialysis patients. Kidney Int. 2002;61(suppl):S94-S98.
18. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int. 2001;59:407-414.
19. Mange K, Joffe M, Feldman H. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med. 2001;344:726-731.
20. Meier-Kriesche H, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes. Transplantation. 2002;74:1377-1381.